Of note, they demonstrated an additional mechanism of action of TLR2 activation, which was based on the TLR2/MyD88-mediated activation of the Wnt pathway, with the induction of the expression of its targets CD44 and Lgr5, which may lead to tumor initiation [46]. Here, MYD88 is linked to neoplasm.